D.E. Shaw & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.8M | Buy |
309,838
+9,975
| +3% | +$581K | 0.01% | 1186 |
|
|
2025
Q4 | $16.2M | Sell |
299,863
-1,151,132
| -79% | -$55.4M | 0.01% | 1379 |
|
|
2025
Q3 | $65.4M | Buy |
1,450,995
+932,773
| +180% | +$43.6M | 0.04% | 536 |
|
|
2025
Q2 | $24M | Sell |
518,222
-240,348
| -32% | -$11.8M | 0.02% | 926 |
|
|
2025
Q1 | $46.3M | Sell |
758,570
-593,717
| -44% | -$34.6M | 0.04% | 513 |
|
|
2024
Q4 | $76.5M | Sell |
1,352,287
-206,452
| -13% | -$11.5M | 0.06% | 414 |
|
|
2024
Q3 | $80.6M | Sell |
1,558,739
-895,363
| -36% | -$42M | 0.07% | 339 |
|
|
2024
Q2 | $102M | Buy |
2,454,102
+1,721,172
| +235% | +$77M | 0.1% | 250 |
|
|
2024
Q1 | $39.7M | Sell |
732,930
-3,663,277
| -83% | -$187M | 0.03% | 569 |
|
|
2023
Q4 | $226M | Buy |
4,396,207
+763,722
| +21% | +$40.1M | 0.2% | 94 |
|
|
2023
Q3 | $211M | Buy |
3,632,485
+2,423,547
| +200% | +$148M | 0.22% | 84 |
|
|
2023
Q2 | $77.3M | Buy |
1,208,938
+456,476
| +61% | +$30.6M | 0.08% | 299 |
|
|
2023
Q1 | $52.2M | Sell |
752,462
-88,876
| -11% | -$6.27M | 0.06% | 412 |
|
|
2022
Q4 | $60.5M | Buy |
841,338
+399,485
| +90% | +$30.1M | 0.07% | 356 |
|
|
2022
Q3 | $31.4M | Sell |
441,853
-295,626
| -40% | -$21.4M | 0.04% | 607 |
|
|
2022
Q2 | $56.8M | Sell |
737,479
-520,735
| -41% | -$39.7M | 0.07% | 344 |
|
|
2022
Q1 | $91.9M | Sell |
1,258,214
-296,812
| -19% | -$19.9M | 0.09% | 261 |
|
|
2021
Q4 | $97M | Buy |
1,555,026
+1,221,838
| +367% | +$71.7M | 0.08% | 286 |
|
|
2021
Q3 | $19.7M | Buy |
333,188
+239,367
| +255% | +$15.8M | 0.02% | 1020 |
|
|
2021
Q2 | $6.27M | Sell |
93,821
-163,138
| -63% | -$10.6M | 0.01% | 1861 |
|
|
2021
Q1 | $16.2M | Sell |
256,959
-43,431
| -14% | -$2.7M | 0.02% | 1054 |
|
|
2020
Q4 | $18.6M | Buy |
300,390
+142,568
| +90% | +$8.77M | 0.02% | 993 |
|
|
2020
Q3 | $9.52M | Sell |
157,822
-1,277,316
| -89% | -$76.9M | 0.01% | 1274 |
|
|
2020
Q2 | $84.4M | Buy |
1,435,138
+780,768
| +119% | +$46.7M | 0.1% | 220 |
|
|
2020
Q1 | $36.5M | Buy |
654,370
+446,410
| +215% | +$27.3M | 0.06% | 375 |
|
|
2019
Q4 | $13.3M | Sell |
207,960
-809,258
| -80% | -$46.3M | 0.02% | 1037 |
|
|
2019
Q3 | $51.6M | Sell |
1,017,218
-628,816
| -38% | -$29.6M | 0.06% | 374 |
|
|
2019
Q2 | $74.6M | Sell |
1,646,034
-2,071,050
| -56% | -$96.5M | 0.09% | 267 |
|
|
2019
Q1 | $177M | Sell |
3,717,084
-8,166,049
| -69% | -$407M | 0.23% | 86 |
|
|
2018
Q4 | $618M | Buy |
11,883,133
+51,707
| +0.4% | +$2.78M | 0.85% | 6 |
|
|
2018
Q3 | $734M | Sell |
11,831,426
-1,197,685
| -9% | -$71.1M | 0.88% | 5 |
|
|
2018
Q2 | $721M | Buy |
13,029,111
+5,356,399
| +70% | +$289M | 0.94% | 5 |
|
|
2018
Q1 | $485M | Buy |
7,672,712
+3,107,597
| +68% | +$200M | 0.66% | 11 |
|
|
2017
Q4 | $280M | Buy |
4,565,115
+2,167,865
| +90% | +$136M | 0.39% | 37 |
|
|
2017
Q3 | $153M | Sell |
2,397,250
-1,246,288
| -34% | -$72.8M | 0.23% | 82 |
|
|
2017
Q2 | $203M | Buy |
3,643,538
+2,789,728
| +327% | +$152M | 0.34% | 48 |
|
|
2017
Q1 | $46.4M | Sell |
853,810
-3,573,354
| -81% | -$196M | 0.08% | 298 |
|
|
2016
Q4 | $259M | Sell |
4,427,164
-2,857,336
| -39% | -$156M | 0.44% | 30 |
|
|
2016
Q3 | $393M | Buy |
7,284,500
+6,016,104
| +474% | +$386M | 0.69% | 12 |
|
|
2016
Q2 | $93.3M | Buy |
1,268,396
+1,075,261
| +557% | +$76M | 0.17% | 128 |
|
|
2016
Q1 | $12.3M | Sell |
193,135
-2,343,884
| -92% | -$148M | 0.02% | 748 |
|
|
2015
Q4 | $175M | Buy |
2,537,019
+1,062,644
| +72% | +$70.2M | 0.26% | 75 |
|
|
2015
Q3 | $87.3M | Buy |
1,474,375
+907,190
| +160% | +$57.6M | 0.13% | 183 |
|
|
2015
Q2 | $37.7M | Buy |
567,185
+473,235
| +504% | +$31.2M | 0.06% | 407 |
|
|
2015
Q1 | $6.06M | Sell |
93,950
-193,394
| -67% | -$12.1M | 0.01% | 1256 |
|
|
2014
Q4 | $17M | Sell |
287,344
-206,265
| -42% | -$11.6M | 0.02% | 789 |
|
|
2014
Q3 | $25.3M | Sell |
493,609
-684,944
| -58% | -$34.2M | 0.03% | 593 |
|
|
2014
Q2 | $57.2M | Buy |
1,178,553
+60,831
| +5% | +$3M | 0.08% | 290 |
|
|
2014
Q1 | $58.1M | Buy |
1,117,722
+1,012,342
| +961% | +$53.9M | 0.08% | 261 |
|
|
2013
Q4 | $5.6M | Sell |
105,380
-3,368
| -3% | -$172K | 0.01% | 1583 |
|
|
2013
Q3 | $5.03M | Sell |
108,748
-82,388
| -43% | -$3.62M | 0.01% | 1583 |
|
|
2013
Q2 | $8.54M | Buy |
+191,136
| New | +$8.3M | 0.02% | 971 |
|
Other funds holding BMY
VCM
VPM
D.E. Shaw & Co's BMY Position: Q1 2026 in Review
D.E. Shaw & Co increased its Bristol-Myers Squibb (BMY) stake by 3.3% in Q1 2026, buying an estimated $581K and bringing the position to 309,838 shares worth $18.8M. The position accounts for 0.01% of the portfolio, ranked #1186.
D.E. Shaw & Co first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $734M in Q3 2018. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- D.E. Shaw & Co held 309,838 shares of Bristol-Myers Squibb worth $18.8M as of Q1 2026.
- D.E. Shaw & Co bought 9,975 Bristol-Myers Squibb shares in Q1 2026, an estimated $581K.
- Bristol-Myers Squibb made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1186 holding.
- D.E. Shaw & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- D.E. Shaw & Co's Bristol-Myers Squibb position peaked at $734M in Q3 2018.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.